Arrhythmogenic right ventricular dysplasia/cardiomyopathy

Heart and Lung: Journal of Acute and Critical Care

Volumn 30, Issue 5, 2001, Pages 360-369

  Harrison, Tracie Culp ^a   Kessler, David ^b  

^a SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^b Austin Heart   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBAMAZEPINE; DISOPYRAMIDE; FLECAINIDE; MEXILETINE; PHENOBARBITAL; PHENYTOIN; PROCAINAMIDE; QUINIDINE; SOTALOL; TOCAINIDE;

ADULT; ARTICLE; CARDIOMYOPATHY; CASE REPORT; CLINICAL FEATURE; DEFIBRILLATOR; FEMALE; HEART ARRHYTHMIA; HEART RIGHT VENTRICLE DYSPLASIA; HISTOLOGY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROGNOSIS; UNITED STATES;

EID: 0034780218     PISSN: 01479563     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhl.2001.117982     Document Type: Article

References (32)

1. Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: A multicenter study
2. Right ventricular dysplasia: Morphological findings in 13 cases
3. Arrhythmogenic right ventricular dysplasia/cardiomyopathy: Review for the clinician
4. Cardiovascular causes of sudden death in young individuals including athletes
5. The locus of a novel gene responsible for arrhythmogenic right ventricular dysplasia characterized by early onset and high penetrance maps to chromosome 10p12-p14
6. Sudden death in young competitive athletes: Clinicopathologic correlations in 22 cases
7. Arrhythmogenic right ventricular cardiomyopathy: Diagnosis, prognosis, and treatment
8. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy
9. Arrhythmogenic right and left ventricular disease: Evaluation by computed tomography and nuclear resonance imaging
10. Right ventricular arrhythmia in the absence of arrhythmogenic dysplasia: MR imaging of myocardial abnormalities
11. Cardioangiographic findings in patients with arrhythmogenic right ventricular dysplasia
12. Time domain analysis and spectral turbulence analysis of the signal averaged ECG identify high-risk subgroups in arrhythmogenic right ventricular cardiomyopathy
13. Time- and frequency-domain analyses of the signal-averaged ECG in patients with arrhythmogenic right ventricular dysplasia
14. Correlation of signal averaged ECG parameters and echocardiographic findings in arrythmogenic right ventricular dysplasia
15. Arrhythmogenic right ventricular dysplasia
16. Arrhythmogenic right ventricular cardiomyopathy and fatty replacement of the right ventricular myocardium: Are they different diseases?
17. Right ventricular dysplasia: Morphological findings in 13 cases
18. In vivo evidente of apoptosis in arrhythmogenic right ventricular cardiomyopathy
19. Arrhythmogenic right ventricular cardiomyopathies: Clinical forms and main differential diagnoses
20. Right ventricular cardiomyopathy and sudden death in young people
21. Characteristics, prognosis and treatment of the ventricular arrhythmias of right ventricular dysplasia
22. Frequency of supraventricular tachyarrhythmias in arrhythmogenic right ventricular dysplasia
23. Arrhythmogenic right ventricular cardiomyopathy in young versus adult patients: Similarities and differences
24. A long-term follow up of 15 patients with arrhythmogenic right ventricular dysplasia
25. Efficacy and safety of d,l-sotalol in patients with ventricular tachycardia and in survivors of cardiac arrest
26. Comparison of d,l-sotalol and implantable defibrillators for treatment of sustained ventricular tachycardia or fibrillation in patients with coronary artery disease
27. Pacing in right ventricular dysplasia after disconnection surgery
28. Right ventricular dysplasia with complete atrioventricular block: Necessity and limitation of left ventricular epicardial pacing
29. Risk stratification of sudden cardiac death and malignant ventricular arrhythmias in right ventricular dysplasia-cardiomyopathy
30. Heart failure in arrhythmogenic right ventricular dysplasia-cardiomyopathy
31. Securing life through technology acceptance: The first six months after transvenous internal cardioverter defibrillator implantation
32. Arrhythmogenic right ventricular cadiomyopathy. Dyslplasia, dystrophy, or myocarditis?